FA info icon.svg Angle down icon.svg Medical equipment data

Problem being addressed

Diabetes Mellitus is a growing world-wide problem. Half of the current cases in the developing world go undetected for 5-9 years after onset, leading to irreversible damage. Current diagnostic techniques are invasive and inconvenient due to weak test sensitivity and the need for drawing blood.

Detailed description of the solution

The Scout DS is a completely non-invasive device used to detect pre-diabetes and type II diabetes in adults. The patient simply places his or her arm on a portable table device, which accurately measures skin biomarkers such as Advanced Glycation End Products, metabolic and microvascular changes.

Relevance to Developing Country Settings

This device is particularly beneficial for developing world context because it provides a prompt indication of whether or not a person likely has diabetes without the need for blood.

Designed/Manufactured by

  • Manufacturer: VeraLight, Inc.
  • Manufacturer location: Albuquerque, New Mexico, United States

Funding Source

VeraLight is a privately-funded company that was founded in 2004 in order to develop the Scout DS technology.

References

Peer-reviewed publication

Ediger, M. N., Olson, B. P., & Maynard, J. D. (2009). Noninvasive optical screening for diabetes. Journal of Diabetes Science and Technology, 3(4), 776-780.

Internally generated reports

Cavanaugh, B., Matter, N., Way, J., Maynard, J. Noninvasive Skin Intrinsic Fluorescence Correlates With Degree of Coronary Artery Calcification. VeraLight. PDF available here.

Externally generated reports

Heubeck, E. (October, 2007). Noninvasive Diabetes Screening Tool Shows Potential. DOC News, Vol. 4 No. 10 7. Link available here.

Approval by regulatory bodies or standards boards

Scout DS has received CE and Health Canada approval for commercial distribution. It has not yet received FDA approval.


Cookies help us deliver our services. By using our services, you agree to our use of cookies.